method for reducing the amount of a serine protease or serine protease zymogen in a composition, method for preparing a composition, plasma derived protein composition, and method for treating a disease
ALFRED WEBER,AZRA PLJEVLJAKOVIC,HANS-PETER SCHWARZ,RUTH MADLENER,SONJA SVATOS,WOLFGANG TESCHNER
申请号：
BR112012029897
公开号：
BR112012029897A2
申请日:
2011.05.26
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
The present invention provides improved methods for the manufacturing of IVIG products. These methods offer various advantages such as reduced loss of IgG during purification and improved quality of final products. In other aspects, the present invention provides aqueous and pharmaceutical compositions suitable for intravenous, subcutaneous, and/or intramuscular administration. In yet other embodiments, the present invention provides methods of treating a disease or condition comprising administration of an IgG composition provided herein.
